DSM and Roquette Take Next Step in Bio-based Succinic Acid


Alternativ







Geleen, The Netherlands, 22 February 2019
Following the successful production of bio-succinic acid under the trademark Biosuccinium® since 2012, Reverdia’s parent companies — Royal DSM, a global science-based company in Nutrition, Health and Sustainable Living, and Roquette, a global leader in plant-based ingredients for Food, Nutrition and Health markets, — have decided on a strategic shift in the continuing operations of their joint venture.

Effective 1 April 2019, the joint venture Reverdia will be dissolved and the partners will transfer the rights and obligations related to Reverdia’s Biosuccinium® plant in Cassano, Italy to Roquette. Under a non-exclusive license from DSM, Roquette will operate the plant and continue serving customers of Biosuccinium®. Customer service, order processing, and marketing and sales will be integrated into Roquette’s existing business to ensure a smooth transition. DSM, the original developer of the Biosuccinium® technology, will assume the role of exclusive licensor, in line with its business model in this field.

Atul Thakrar, President of Bio-based Products and Services at DSM says, “The Reverdia joint venture has proven Biosuccinium® technology to be the most sustainable and competitive bio-succinic acid on the market today. We have gone well beyond the start-up phase and the Biosuccinium® brand will continue to grow under the leadership of our partner Roquette. This is an example of DSM doing what it does best — establishing market-leading technologies and commercializing them.”

After the success of the collaboration with DSM through the joint venture, we will integrate the Biosuccinium® product line within our global business organisation. Our sales force will continue to support our customers’ growth,” says Bruno Plancke, Vice President of the Industry Global Business Unit at Roquette.

DSM, the original developer of the Biosuccinium® technology, will become the exclusive licensor to strategic customers and other third parties interested in the integration of the Biosuccinium® production process into their value chains. Bio-succinic acid is a platform molecule with applications in a range of large-volume markets. DSM’s technology has matured to a point where the roll-out potential is significant enough to warrant a focused effort on licensing.


DSM – Bright Science. Brighter Living.TM
Royal DSM is a global purpose-led, science-based company in Nutrition, Health and Sustainable Living. DSM’s purpose is to create brighter lives for all. DSM addresses with its products and solutions some of the world’s biggest challenges whilst creating simultaneously economic-, environmental- and societal value for all its stakeholders; customers, employees, shareholders, and society-at-large. DSM delivers innovative solutions for human nutrition, animal nutrition, personal care and aroma, medical devices, green products and applications, and new mobility and connectivity. DSM and its associated companies deliver annual net sales of about €10 billion with approximately 23,000 employees. The company was founded in 1902 and is listed on Euronext Amsterdam. More information can be found at www.dsm.com.

Roquette – Offering the best of nature
Roquette is a global leader in plant-based ingredients and a pioneer of new vegetal proteins.

In collaboration with its customers and partners, the Group addresses current and future societal challenges by unlocking the potential of Nature to offer the best ingredients for Food, Nutrition and Health markets. Each of these ingredients responds to unique and essential needs, and they enable healthier lifestyles.

Thanks to a constant drive for innovation and a long-term vision, the Group is committed to improving the well-being of millions of people all over the world while taking care of resources and territories.

Roquette currently operates in over 100 countries, has a turnover of around €3.3 billion and employs 8,400 people worldwide.

« back